Contract Pharmaceutical Fermentation Services Market Forecast, Trend Analysis & Competition Tracking - Global Review 2018 to 2026

  • Published : Mar-2019
  • Tables : 36
  • Figures : 49
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT1517MR
  • Format : ppt
contract pharmaceutical fermentation services market

Highly Fragmented Market Necessitating Adoption of Unique Strategies

The contract pharmaceutical services manufacturing market is fairly fragmented, with manifold contract manufacturing organizations (CMOs) showing high dependence on limited number of clients. To gain a competitive edge in this highly fragmented market, contract pharmaceutical fermentation services’ providers are creating unique strategies based on prevailing pharmaceutical industry landscape and trends.

To capitalize on the growing trend of pharmaceutical companies avoiding internal capacity investment to embrace outsourcing, contract pharmaceutical fermentation services’ providers continue to embed advancing technology in their processes. Further, several contract pharmaceutical fermentation services providers are indulging into collaborations with local integrators. To move ahead of the competition in contract pharmaceutical fermentation services market, leading players are focusing on extending and diversifying their businesses, as pharmaceutical industries turn to outsourcing to CMOs to underpin gains.

  • January 2019 - A leading player in contract pharmaceutical fermentation services market, AbbVie, has collaborated with a privately held immunotherapy firm, Tizona Therapeutics, to manufacture and commercialize CD39-targeted therapeutics, such as TTX-030, an antibody for treating cancer.
  • March 2018 - AbbVie, Inc. won Life Science Leader CMO award for contract manufacturing and reinforced its position in contract pharmaceutical fermentation services market.
  • January 2019 - Another leading player in contract pharmaceutical fermentation services market, Boehringer Ingelheim International GmbH announced commencement of its capacity expansion at the company’s commercial manufacturing site for biologics located in China.
  • December 2018 - Lonza announced plans about establishing a bio manufacturing base in China. Lonza has inked an agreement with GE Healthcare under which GE Healthcare will provide a biologics facility to a site in Guangzhou. The base is anticipated to be functional in 2020.

Detailed profiles of other leading market players operating in contract pharmaceutical fermentation services market have also been included in contract pharmaceutical fermentation services market report. Key players operating in contract pharmaceutical fermentation services market include AbbVie, Inc., Aumgene Biosciences, EKF Diagnostics-Stanbio, Boehringer Ingelheim International GmbH, Biocon, AMRI, Pfizer, Lonza, CordenPharma International, and Fujifilm Holdings Corporation.

key market influencers and regional impact

Evolving Use of Fermentation Techniques for Developing Active Pharmaceutical Ingredients Creating Opportunities

The overall pharmaceutical industry has been changing and developing at a rapid pace with several manufacturing firms struggling with massive challenges caused by high market growth, frequently changing regulations, novel therapy and medicine forms as well as progressing digitization. To address such challenges, pharmaceutical medicines’ manufacturers are increasingly mimicking already existing manufacturing equipment to further transfer them to contract manufacturing service providers. Being the core for production of a wide range of pharmaceutical based products, microbial fermentation has frequently evolved in recent past. As a result several pharmaceutical manufacturers are deriving medical products from fermented products encompassing active pharmaceutical ingredients (API), which is further creating demand for contract pharmaceutical fermentation services for bulk supply. The growing adoption of microbial fermentation as a production method for therapeutic proteins, fragmented antibodies, intermediates, peptides, etc., has become an optimal economic route for pharmaceutical companies to meet production demand and market delivery time. This burgeoning demand for fermentation processes in tandem with the rapidly expanding pharmaceutical industry are likely to fuel growth in contract pharmaceutical fermentation services market in forthcoming years.

Growing Demand for Time-Efficient Drug Development to Underpin Market Growth

Though the pharmaceutical industry is rapidly changing and accelerating, the basic understanding of diverse diseases at a molecular level is improving constantly. This growing understanding of different diseases is further accelerating the demand for faster production. Amid the burgeoning production demand, several pharmaceutical companies are increasingly collaborating with contract pharmaceutical fermentation services’ providers to introduce innovative molecules in the market. Further the growing prevalence of diverse diseases, such as cancer, anemia, diabetes, rheumatoid arthritis, etc., is likely to boost demand for diverse pharmaceutical products with applications in disease management. This widespread prevalence of diseased population that is constantly requiring therapies and treatment is triggering the demand for time-efficient drug production. As contract pharmaceutical fermentation services’ providers offer reduced time-to-market for various key pharmaceutical products by collaborating with molecule owners and giving platforms for time-efficient drug development and other analytical services, their demand is set to grow. This growing trend is likely to trigger growth in contract pharmaceutical fermentation services market during the forecast period.

Complexities Associated with Contract Pharmaceutical Fermentation Services Dampening Market Growth

Despite extensive utilization of fermentation processes, the technology is yet to gain maturity like chemical synthesis, in terms of adoption of mathematical models and optimization techniques. The significant fermentation challenges, such as scale up and scale down fermentation, controlling insightful process parameters, mass transfer, and establishing novel sensors have been restraining market growth. Further the challenges associated with advanced therapy medicinal products that demand thoughtful and appropriate facility design and equipment continue to hinder contract pharmaceutical fermentation services market growth. As contract pharmaceutical fermentation services need huge capital investment for set-ups and fulfilling technical staff requirements, several market players deal with large-scale fermentation challenges. Such challenges are likely to hamper growth in contract pharmaceutical fermentation services market in forthcoming years.

Growing Need for Differentiation and Biosimilar and Biologic Manufacturing Presenting Strong Growth Opportunities

With manifold manufacturers, contract pharmaceutical fermentation services market remains highly fragmented, propelling service providers to seek novel and innovative ways of differentiating their services from counterparts. Amid the rigorous competition in contract pharmaceutical fermentation services market, the service providers are increasingly focusing on value-added services which is likely to bring tremendous changes in the market, thereby paving way for growth opportunities.

Definition

Contract pharmaceutical fermentation services are mainly used by pharmaceutical industries when they need abundant fermentation of products required for the development of drug formulations. Contract pharmaceutical fermentation services deploy different kinds of fermentation techniques with the help of skilled staff.

About the Report

The report on contract pharmaceutical fermentation services market offers a comprehensive evaluation of the business opportunities in contract pharmaceutical fermentation services market. It also offers insights on contract pharmaceutical fermentation services market outlook, and list of service providers in the contract pharmaceutical fermentation services market for the duration from 2018 to 2026.

Segmentation

The Fact.MR report on contract pharmaceutical fermentation services offers a comprehensive taxonomy of the contract pharmaceutical fermentation services market on the basis of contract pharmaceutical fermentation service type, platform, product type, and end user of contract pharmaceutical fermentation services. On the basis of service type, the global contract pharmaceutical fermentation services market has been segmented into development services and commercial services. On the basis of platform, the global contract pharmaceutical fermentation services market has been segmented into bacterial and fungal/yeast. Based on product type, the global contract pharmaceutical fermentation services market has been segmented into bio-therapeutics, enzymes, peptides, plasmids, cytokines & growth factors, vaccines, others (fusion proteins, etc.). By end user, the global contract pharmaceutical fermentation services market has been segmented into pharmaceutical companies, biotechnology companies, animal health companies, and academic & research institutes. Based on region, the contract pharmaceutical fermentation services market has been bifurcated into North America, Latin America, Europe, and Asia Pacific excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA).

Additional Questions Answered

Some of the additional questions addressed in report on the contract pharmaceutical fermentation services market are-

  • What is the revenue potential of the contract pharmaceutical fermentation services market across emerging economies?
  • What will be the contract pharmaceutical fermentation services market size in 2022?
  • Which are top five players in contract pharmaceutical fermentation services market, and what will be their y-o-y growth during the contract pharmaceutical fermentation services study period?
  • Which product type of contract pharmaceutical fermentation services market holds maximum gains for contract pharmaceutical fermentation services market players?
  • Which country will create most lucrative opportunities for contract pharmaceutical fermentation services market players during the forecast period?
  • Which service type is witnessing monopoly in contract pharmaceutical fermentation services market, and what will be its market size in 2024?
  • What will be y-o-y growth rate of contract pharmaceutical fermentation services market in North America in next three years?

Research Methodology

Key insights provided on contract pharmaceutical fermentation services market are fully based on dynamic research methodology deployed to create the contract pharmaceutical fermentation services market report. The report on Contract pharmaceutical fermentation services is made of comprehensive primary and secondary researches to obtain significant information related to aspects of the Contract pharmaceutical fermentation services market. Analysts have performed an in-depth research to attain the numbers mentioned in the report, such as, CAGR, y-o-y growth and revenue share of all the market segments.

The unique research followed by Fact.MR offers authenticity of every minute detail published in the report. The actionable insights related to Contract pharmaceutical fermentation services market are presented in easy to understand way to help clients in make well-informed decisions for future growth of their businesses in the contract pharmaceutical fermentation services market. 

1. Executive Summary
      1.1. Market Overview
      1.2. Market Analysis
      1.3. FACT.MR Analysis and Recommendations

2. Market Introduction
      2.1. Market Introduction
      2.2. Market Definition
      2.3. Market Taxonomy

3. Global Market Outlook

4. Market Dynamics
      4.1. Growth Drivers and Impact Analysis
      4.2. Industry Challenges and Impact Analysis 
      4.3. Opportunity Assessment in Contract Pharmaceutical Fermentation Services Market
      4.4. Industry trends and Impact analysis

5. Global Contract Pharmaceutical Fermentation Services Market Analysis and Forecast
      5.1. Global Contract Pharmaceutical Fermentation Services Market Outlook
             5.1.1. Market Value(US$ Mn) and Volume Forecast and Analysis
             5.1.2. Regional Demand Assessment
                       5.1.2.1. Market Value Share by Region
      5.2. Contract Pharmaceutical Fermentation Services Market Analysis by Platform
             5.2.1. Bacterial
             5.2.2. Fungal/Yeast 
      5.3. Contract Pharmaceutical Fermentation Services Market Analysis by Service Type
             5.3.1. Development Services
             5.3.2. Commercial Services 
      5.4. Contract Pharmaceutical Fermentation Services Market Analysis by Product Type
             5.4.1. Biotherapeutics
             5.4.2. Enzymes
             5.4.3. Peptides
             5.4.4. Plasmids
             5.4.5. Cytokines & Growth Factors
             5.4.6. Vaccines
             5.4.7. Others 
      5.5. Contract Pharmaceutical Fermentation Services Market Analysis by End User
             5.5.1. Pharmaceutical Companies
             5.5.2. Biotechnology Companies
             5.5.3. Animal Health Companies
             5.5.4. Animal Health Companies Institutes 

6. North America Contract Pharmaceutical Fermentation Services Market Analysis
      6.1. Introduction
             6.1.1. North America Business Outlook 
             6.1.2. North America Contract Pharmaceutical Fermentation Services Market Outlook
      6.2. North America Contract Pharmaceutical Fermentation Services Market Outlook
             6.2.1. Market Value(US$ Mn) Forecast and Analysis
             6.2.2. Country Wise Demand Assessment
                       6.2.2.1. US Market Value Share
                       6.2.2.2. Canada Market Value Share
      6.3. Contract Pharmaceutical Fermentation Services Market Analysis by Platform
             6.3.1. Bacterial
             6.3.2. Fungal/Yeast 
      6.4. Contract Pharmaceutical Fermentation Services Market Analysis by Service Type
             6.4.1. Development Services
             6.4.2. Commercial Services 
      6.5. Contract Pharmaceutical Fermentation Services Market Analysis by Product Type
             6.5.1. Biotherapeutics
             6.5.2. Enzymes
             6.5.3. Peptides
             6.5.4. Plasmids
             6.5.5. Cytokines & Growth Factors
             6.5.6. Vaccines
             6.5.7. Others 
      6.6. Contract Pharmaceutical Fermentation Services Market Analysis by End User
             6.6.1. Pharmaceutical Companies
             6.6.2. Biotechnology Companies
             6.6.3. Animal Health Companies
             6.6.4. Animal Health Companies Institutes 
      6.7. Market Attractiveness Analysis
      6.8. Impact Assessment of Market Forces

7. Latin America Contract Pharmaceutical Fermentation Services Market Analysis 
      7.1. Introduction
             7.1.1. Latin America Business Outlook 
             7.1.2. Latin America Contract Pharmaceutical Fermentation Services Market Outlook
      7.2. Latin America Contract Pharmaceutical Fermentation Services Market Outlook
             7.2.1. Value(US$ Mn) Forecast and Analysis
             7.2.2. Country Wise Demand Assessment
                       7.2.2.1. Argentina Market Value Share
                       7.2.2.2. Brazil Market Value Share 
                       7.2.2.3. Mexico Market Value Share
                       7.2.2.4. Rest of LATAM Market Value Share 
      7.3. Contract Pharmaceutical Fermentation Services Market Analysis by Platform
             7.3.1. Bacterial
             7.3.2. Fungal/Yeast 
      7.4. Contract Pharmaceutical Fermentation Services Market Analysis by Service Type
             7.4.1. Development Services
             7.4.2. Commercial Services 
      7.5. Contract Pharmaceutical Fermentation Services Market Analysis by Product Type
             7.5.1. Biotherapeutics
             7.5.2. Enzymes
             7.5.3. Peptides
             7.5.4. Plasmids
             7.5.5. Cytokines & Growth Factors
             7.5.6. Vaccines
             7.5.7. Others 
      7.6. Contract Pharmaceutical Fermentation Services Market Analysis by End User
             7.6.1. Pharmaceutical Companies
             7.6.2. Biotechnology Companies
             7.6.3. Animal Health Companies
             7.6.4. Animal Health Companies Institutes 
      7.7. Market Attractiveness Analysis
      7.8. Impact Assessment of Market Forces

8. Europe Contract Pharmaceutical Fermentation Services Market Analysis
      8.1. Introduction
             8.1.1.  Europe Business Outlook 
             8.1.2.  Europe Contract Pharmaceutical Fermentation Services Market Outlook
      8.2. Europe Contract Pharmaceutical Fermentation Services Market Outlook
             8.2.1. Value(US$ Mn) Forecast and Analysis
             8.2.2. Country Wise Demand Assessment
                       8.2.2.1. Germany Market Value Share
                       8.2.2.2. UK Market Value Share 
                       8.2.2.3. France Market Value Share
                       8.2.2.4. Italy Market Value Share 
                       8.2.2.5. Spain Market Value Share
                       8.2.2.6. Russia Market Value Share
                       8.2.2.7. Poland Market Value Share
                       8.2.2.8. Rest of Europe Market Value Share    
      8.3. Contract Pharmaceutical Fermentation Services Market Analysis by Platform
             8.3.1. Bacterial
             8.3.2. Fungal/Yeast 
      8.4. Contract Pharmaceutical Fermentation Services Market Analysis by Service Type
             8.4.1. Development Services
             8.4.2. Commercial Services 
      8.5. Contract Pharmaceutical Fermentation Services Market Analysis by Product Type
             8.5.1. Biotherapeutics
             8.5.2. Enzymes
             8.5.3. Peptides
             8.5.4. Plasmids
             8.5.5. Cytokines & Growth Factors
             8.5.6. Vaccines
             8.5.7. Others 
      8.6. Contract Pharmaceutical Fermentation Services Market Analysis by End User
             8.6.1. Pharmaceutical Companies
             8.6.2. Biotechnology Companies
             8.6.3. Animal Health Companies
             8.6.4. Animal Health Companies Institutes 
      8.7. Market Attractiveness Analysis
      8.8. Impact Assessment of Market Forces

9. Asia Pacific Excluding Japan Contract Pharmaceutical Fermentation Services Market Analysis
      9.1. Introduction
             9.1.1. Asia Pacific Excluding Japan Business Outlook 
             9.1.2. Asia Pacific Excluding Japan Contract Pharmaceutical Fermentation Services Market Outlook
      9.2. Asia Pacific Excluding Japan Contract Pharmaceutical Fermentation Services Market Outlook
             9.2.1. Value(US$ Mn), Forecast and Analysis
             9.2.2. Country Wise Demand Assessment
                       9.2.2.1. India Market Value Share
                       9.2.2.2. China Market Value Share 
                       9.2.2.3. Australia & New Zealand Market Value Share
                       9.2.2.4. Rest of APEJ Market Value Share 
      9.3. Contract Pharmaceutical Fermentation Services Market Analysis by Platform
             9.3.1. Bacterial
             9.3.2. Fungal/Yeast 
      9.4. Contract Pharmaceutical Fermentation Services Market Analysis by Service Type
             9.4.1. Development Services
             9.4.2. Commercial Services 
      9.5. Contract Pharmaceutical Fermentation Services Market Analysis by Product Type
             9.5.1. Biotherapeutics
             9.5.2. Enzymes
             9.5.3. Peptides
             9.5.4. Plasmids
             9.5.5. Cytokines & Growth Factors
             9.5.6. Vaccines
             9.5.7. Others 
      9.6. Contract Pharmaceutical Fermentation Services Market Analysis by End User
             9.6.1. Pharmaceutical Companies
             9.6.2. Biotechnology Companies
             9.6.3. Animal Health Companies
             9.6.4. Animal Health Companies Institutes 
      9.7. Market Attractiveness Analysis
      9.8. Impact Assessment of Market Forces

10. Japan Contract Pharmaceutical Fermentation Services Market Analysis
      10.1. Introduction
             10.1.1. Japan Business Outlook 
             10.1.2. Japan Contract Pharmaceutical Fermentation Services Market Outlook
      10.2. Japan Contract Pharmaceutical Fermentation Services Market Outlook
             10.2.1. Market Value(US$ Mn) and Volume Forecast and Analysis
      10.3. Contract Pharmaceutical Fermentation Services Market Analysis by Platform
             10.3.1. Bacterial
             10.3.2. Fungal/Yeast 
      10.4. Contract Pharmaceutical Fermentation Services Market Analysis by Service Type
             10.4.1. Development Services
             10.4.2. Commercial Services 
      10.5. Contract Pharmaceutical Fermentation Services Market Analysis by Product Type
             10.5.1. Biotherapeutics
             10.5.2. Enzymes
             10.5.3. Peptides
             10.5.4. Plasmids
             10.5.5. Cytokines & Growth Factors
             10.5.6. Vaccines
             10.5.7. Others 
      10.6. Contract Pharmaceutical Fermentation Services Market Analysis by End User
             10.6.1. Pharmaceutical Companies
             10.6.2. Biotechnology Companies
             10.6.3. Animal Health Companies
             10.6.4. Animal Health Companies Institutes 
      10.7. Market Attractiveness Analysis
      10.8. Impact Assessment of Market Forces

11. MEA Contract Pharmaceutical Fermentation Services Market Analysis
      11.1. Introduction
             11.1.1. MEA Business Outlook 
             11.1.2. MEA Contract Pharmaceutical Fermentation Services Market Outlook
      11.2. MEA Contract Pharmaceutical Fermentation Services Market Outlook
             11.2.1. Value(US$ Mn) Forecast and Analysis
             11.2.2. Country Wise Demand Assessment
                       11.2.2.1. GCC Countries Market Value Share
                       11.2.2.2. South Africa Market Value Share
                       11.2.2.3. Rest of MEA Market Value Share 
      11.3. Contract Pharmaceutical Fermentation Services Market Analysis by Platform
             11.3.1. Bacterial
             11.3.2. Fungal/Yeast 
      11.4. Contract Pharmaceutical Fermentation Services Market Analysis by Service Type
             11.4.1. Development Services
             11.4.2. Commercial Services 
      11.5. Contract Pharmaceutical Fermentation Services Market Analysis by Product Type
             11.5.1. Biotherapeutics
             11.5.2. Enzymes
             11.5.3. Peptides
             11.5.4. Plasmids
             11.5.5. Cytokines & Growth Factors
             11.5.6. Vaccines
             11.5.7. Others 
      11.6. Contract Pharmaceutical Fermentation Services Market Analysis by End User
             11.6.1. Pharmaceutical Companies
             11.6.2. Biotechnology Companies
             11.6.3. Animal Health Companies
             11.6.4. Animal Health Companies Institutes 
      11.7. Market Attractiveness Analysis
      11.8. Impact Assessment of Market Forces

12. Forecast Factors
      12.1. Forecast Factors – Relevance and Impact
      12.2. Market Size and Forecast Factors - Relative Weightage

13. Competitive Assessment
      13.1. Contract Pharmaceutical Fermentation Services Market Structure, Company Share Analysis
      13.2. Contract Pharmaceutical Fermentation Services Market Structure, By Tier
      13.3.Contract Pharmaceutical Fermentation Services Market Competition - a Dashboard View

14.  Company Profiles
      14.1. AbbVie, Inc.
             14.1.1. Manufacturing facilities Across Globe, 2017
             14.1.2. Region Wise Share of Target Product – Company Benchmark
             14.1.3. Key Financials
             14.1.4. SWOT Analysis
      14.2. Aumgene Biosciences 
      14.3. EKF Diagnostics – Stanbio
      14.4. Boehringer Ingelheim International GmbH
      14.5. Biocon
      14.6. AMRI
      14.7. Pfizer
      14.8. Lonza
      14.9. CordenPharma International
      14.10. Fujifilm Holdings Corporation

15. Assumptions and Acronyms Used

16. Research Methodology

List of Tables

Table 01: Expenditure on Health (% of GDP) by Country, 2016-2021 (1/2)
Table 02: Expenditure on Health (% of GDP) by Country, 2016-2021 (2/2)
Table 03: Global Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) & Forecast 2013–2026, By Region
Table 04: Global Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) & Forecast 2013–2026, By Platform
Table 05: Global Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) & Forecast 2013–2026, By Service Type
Table 06: Global Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) & Forecast 2013–2026, By Product Type
Table 07: Global Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) & Forecast 2013–2026, By End User
Table 08: North America Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Platform
Table 09: North America Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Service Type
Table 10: North America Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Product Type
Table 11: North America Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 12: North America Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 13: Latin America Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Platform
Table 14: Latin America Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Service Type
Table 15: Latin America Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Product Type
Table 16: Latin America Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 17: Latin America Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 18: Europe Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Platform
Table 19: Europe Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Service Type
Table 20: Europe Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Product Type
Table 21: Europe Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 22: Europe Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 23: APEJ Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Platform
Table 24: APEJ Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Service Type
Table 25: APEJ Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Product Type
Table 26: APEJ Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 27: APEJ Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 28: Japan Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Platform
Table 29: Japan Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Service Type
Table 30: Japan Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Product Type
Table 31: Japan Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 32: MEA Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Platform
Table 33: MEA Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Service Type
Table 34: MEA Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Product Type
Table 35: MEA Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 36: MEA Contract Pharmaceutical Fermentation Services Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country

 

List of Figures

Figure 01: Global Healthcare Expenditure in US$ Bn (2013–2020)
Figure 02: Global Contract Pharmaceutical Fermentation Services Market Value Analysis and Forecast, 2016–2026 (US$ Mn)
Figure 03: Global Contract Pharmaceutical Fermentation Services Market Absolute $ Opportunity (US$ Mn), 2017–2026
Figure 04: Global Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis 2018–2026 , By Region
Figure 05: Global Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis 2018–2026 , By Platform
Figure 06: Global Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis 2018–2026 , By Service Type
Figure 07: Global Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis 2018–2026 , By Product Type
Figure 08: Global Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis 2018–2026 , By End User
Figure 09: North America Contract Pharmaceutical Fermentation Services Market Value Analysis (US$ Mn), 2013–2017
Figure 10: North America Contract Pharmaceutical Fermentation Services Market Value Analysis (US$ Mn), 2017-2026
Figure 11: North America Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Platform, 2018–2026
Figure 12: North America Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Service Type, 2018–2026
Figure 13: North America Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Product Type, 2018–2026
Figure 14: North America Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By End User, 2018–2026
Figure 15: North America Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Country, 2018–2026
Figure 16: Latin America Contract Pharmaceutical Fermentation Services Market Value Analysis (US$ Mn), 2013–2017
Figure 17: Latin America Contract Pharmaceutical Fermentation Services Market Value Analysis (US$ Mn), 2017-2026
Figure 18: Latin America Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Platform, 2018–2026
Figure 19: Latin America Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Service Type, 2018–2026
Figure 20: Latin America Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Product Type, 2018–2026
Figure 21: Latin America Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By End User, 2018–2026
Figure 22: Latin America Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Country, 2018–2026
Figure 23: Europe Contract Pharmaceutical Fermentation Services Market Value Analysis (US$ Mn), 2013–2017
Figure 24: Europe Contract Pharmaceutical Fermentation Services Market Value Analysis (US$ Mn), 2017-2026
Figure 25: Europe Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Platform, 2018–2026
Figure 26: Europe Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Service Type, 2018–2026
Figure 27: Europe Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Product Type, 2018–2026
Figure 28: Europe Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By End User, 2018–2026
Figure 29: Europe Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Country, 2018–2026
Figure 30: APEJ Contract Pharmaceutical Fermentation Services Market Value Analysis (US$ Mn), 2013–2017
Figure 31: APEJ Contract Pharmaceutical Fermentation Services Market Value Analysis (US$ Mn), 2017-2026
Figure 32: APEJ Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Platform, 2018–2026
Figure 33: APEJ Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Service Type, 2018–2026
Figure 34: APEJ Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Product Type, 2018–2026
Figure 35: APEJ Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By End User, 2018–2026
Figure 36: APEJ Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Country, 2018–2026
Figure 37: Japan Contract Pharmaceutical Fermentation Services Market Value Analysis (US$ Mn), 2013–2017
Figure 38: Japan Contract Pharmaceutical Fermentation Services Market Value Analysis (US$ Mn), 2017-2026
Figure 39: Japan Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Platform, 2018–2026
Figure 40: Japan Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Service Type, 2018–2026
Figure 41: Japan Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Product Type, 2018–2026
Figure 42: Japan Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By End User, 2018–2026
Figure 43: MEA Contract Pharmaceutical Fermentation Services Market Value Analysis (US$ Mn), 2013–2017
Figure 44: MEA Contract Pharmaceutical Fermentation Services Market Value Analysis (US$ Mn), 2017-2026
Figure 45: MEA Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Platform, 2018–2026
Figure 46: MEA Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Service Type, 2018–2026
Figure 47: MEA Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Product Type, 2018–2026
Figure 48: MEA Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By End User, 2018–2026
Figure 49: MEA Contract Pharmaceutical Fermentation Services Market Attractiveness Analysis By Country, 2018–2026

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development